Home > Healthcare > Medical Devices > Surgical Devices > Urinary Incontinence Treatment Devices Market

Urinary Incontinence Treatment Devices Market Size

Report ID: GMI8190
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Urinary Incontinence Treatment Devices Market Size

Urinary Incontinence Treatment Devices Market size was valued at around USD 3.1 billion in 2023 and is expected to expand at a CAGR of 8.6% between 2024 and 2032. Factors such as increasing prevalence of urinary incontinence (UI), growing incidence of prostate cancer coupled with rise in target population base for urethral disorders are propelling the market growth over the analysis period.

To get key market trends

Download Free Sample

The rising prevalence of urinary incontinence conditions has led to an increased demand for urinary incontinence treatment devices globally. Factors including the aging population, longer life expectancies, dietary and lifestyle changes, and an increase in obesity and diabetes rates among others are all contributing to the rising global prevalence of UI. For instance, according to The Epidemiology of Incontinence (EPIC) study, the prevalence of UI is estimated to be 8.7% worldwide. Further, the disease is more prominent in women due to several factors including, menopause, delivery, obesity, and diabetes.

Urinary Incontinence Treatment Devices Market Report Attributes
Report Attribute	Details
Base Year:	2023
Urinary Incontinence Treatment Devices Market Size in 2023:	USD 3.1 Billion
Forecast Period:	2024 - 2032
Forecast Period 2024 - 2032 CAGR:	8.6%
2032 Value Projection:	USD 6.5 Billion
Historical Data for:	2018 - 2023
No. of Pages:	130
Tables, Charts & Figures:	226
Segments covered:	Product, Incontinence Type, Category, End-use, and Region
Growth Drivers:	Increasing prevalence of urinary incontinence (UI) Technological advancements in devices and surgical techniques Growing incidence of prostate cancer
Pitfalls & Challenges:	High procedural cost Risks and complications associated with the procedures

Learn more about the key segments shaping this market

Download Free Sample

Additionally, Asia's older adult female population was found to have the highest prevalence of urine incontinence, at 45.1%. Therefore, the growing incidence of UI among the aging population emphasizes the necessity for urinary incontinence treatment devices in order to enhance the quality of life of affected individuals.

Urinary incontinence treatment devices refer to a range of medical devices designed to assist in the management and treatment of urinary incontinence. These devices are intended to help individuals with urinary incontinence regain control over their bladder function or provide support to prevent leakage.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market valuation of the urinary incontinence treatment devices was exceeded USD 3.1 billion in 2023 and is expected to reach around USD 6.5 billion by 2032, owing to the increasing prevalence of urinary incontinence (UI), growing incidence of prostate cancer, coupled with rise in target population base for urethral disorders.

The urethral slings segment was valued at over USD 1.5 billion in 2023 and will grow significantly through 2032 attributed to the rising demand for minimally invasive procedures globally.

North America urinary incontinence treatment devices industry accounted for USD 1 billion in 2023 and is predicted to witness substantial growth through 2032, owing to the awareness initiatives encouraging more people to seek medical attention.

Becton, Dickinson and Company, Boston Scientific Corporation, B Braun Melsungen AG, Caldera Medical Inc., Coloplast A/S, ConvaTec Group plc, Hollister Incorporated, Medtronic plc, PROMEDON GmbH, Teleflex Incorporated, and Zephyr Surgical Implants.